drugset / Trial / NCT00853996
Acolbifene in Preventing Cancer in Premenopausal Women at High Risk of Breast Cancer
Phase 2
Completed
25 enrolled
University of Kansas Medical Center
National Cancer Institute (NCI) · collab
NaSingle-groupOpen-labelPrevention
Summary
This phase II trial is studying how well acolbifene works in preventing cancer in premenopausal women at high risk of breast cancer. Chemoprevention is the use of certain drugs to keep cancer from forming. The use of acolbifene may stop cancer from growing or coming back.
Timeline
- Start
- 2009-02
- Primary completion
- 2010-12
- Completion
- 2010-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | acolbifene | Other / unclassified | 20 mg | Oral |